Research programme: G protein-coupled receptor-targeted antibody - Debiopharm/MSM Protein Technologies
Alternative Names: Debio 0929Latest Information Update: 16 Jul 2016
At a glance
- Originator Debiopharm Group; MSM Protein Technologies
- Class Antibodies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Switzerland (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in USA (Parenteral)
- 30 Jul 2009 Early research in Cancer in Switzerland (Parenteral)